Lifeline
DeviceSurgical arteriovenous fistula formation with the use of Lifeline blood vessel
Other names: Tissue engineered blood vessel
NCT Number: NCT00850252
This study will assess the safety and efficacy of a completely autologous and completely biological tissue engineered blood vessel (TEBV) called Lifeline™ used as an arteriovenous fistula for dialysis access.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 1 / Phase 2
Instituto Argentino de Diagnostico y Tratamiento, Buenos Aires, Argentina
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical arteriovenous fistula formation with the use of Lifeline blood vessel
Other names: Tissue engineered blood vessel
Time frame: minimum 3 months
Time frame: 36 months
Looking for future studies?
Notify MeCytograft Tissue Engineering
Industry
Use of a Completely Autologous and Completely Biological Tissue Engineered Blood Vessel Lifeline as an Arteriovenous Fistula in Hemodialysis Patients - Safety and Efficacy Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06466421
Chronic Disease, Chronic Kidney Disease-associated Pruritus
Tanta, Elgharbia, Egypt
View Trial DetailsNCT00618033
Chronic Disease, Disease Attributes
New York, United States
View Trial DetailsNCT05339139
Acute Kidney Injury, Chronic Disease
Little Rock, Arkansas, United States
View Trial DetailsNCT05309785
CKD Stage 4, CKD Stage 5
Montreal, Quebec, Canada
View Trial Details